Appointment of Nominated Advisor and Joint Broker

RNS Number : 4609N
Animalcare Group PLC
01 February 2021
 

Animalcare Group plc

 

 (the "Company" or the "Group")

 

Appointment of Nominated Advisor and Joint Broker

 

1 February 2021.  Animalcare Group plc (AIM: ANCR), the international animal health business, announces the appointment, with immediate effect, of  Stifel Nicolaus Europe Limited as the Company's nominated advisor and joint broker. Panmure Gordon will continue to act as joint broker.

 

 

For further information please contact:  

 

Animalcare Group plc

Jenny Winter, Chief Executive Officer

Chris Brewster, Chief Financial Officer

Media relations

+44 (0)1904 487 687

 

 

communications@animalcaregroup.com

 

Stifel Nicolaus Europe Limited 
(Nominated Adviser & Joint Broker)

Ben Maddison

Fred Walsh

Nick Adams

 

+44 (0)20 7710 7600

Panmure Gordon

(Joint Broker)

Corporate Finance

Freddy Crossley/Emma Earl

Corporate Broking

Rupert Dearden

 

+44 (0)20 7886 2500



 

About Animalcare   www.animalcaregroup.com

 

Animalcare Group plc is a UK AIM-listed international veterinary sales and marketing organisation. Animalcare operates in seven countries and exports to approximately 32 countries in Europe and a further 16 worldwide. The Group is focused on bringing new and innovative products to market through its own development pipeline, partnerships and via acquisition.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPEAFFFDDPFEAA
UK 100